Amesergide
id:
amesergide-277-17638799
title:
Amesergide
text:
Amesergide is a serotonin receptor antagonist of the ergoline and lysergamide families related to methysergide which was under development by Eli Lilly and Company for the treatment of a variety of conditions including depression, anxiety, schizophrenia, male sexual dysfunction, migraine, and thrombosis but was never marketed. It reached phase II clinical trials for the treatment of depression, erectile dysfunction, and premature ejaculation prior to the discontinuation of its development.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Amesergide
date created:
date modified:
2023-12-23T09:07:08Z
main entity:
{"identifier":"Q27074433","url":"https://www.wikidata.org/entity/Q27074433"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/a1/Amesergide.svg","width":785,"height":1505}
fields total:
13
integrity:
15